# FDA Inspection 1084988 - Seraplex Inc - March 22, 2019

Source: https://www.keypedia.com/records/fda_inspections/seraplex-inc/233bff5f-55ff-4a88-afc4-a3e4f0331b6f
Source feed: FDA_Inspections

> FDA Inspection 1084988 for Seraplex Inc on March 22, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1084988
- Company Name: Seraplex Inc
- Inspection Date: 2019-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1232805 - 2024-03-08](https://www.keypedia.com/records/fda_inspections/seraplex-inc/c0111a88-9540-4b48-8dbb-22b53fd4a678)
- [FDA Inspection 792878 - 2012-07-25](https://www.keypedia.com/records/fda_inspections/seraplex-inc/44c3c888-f049-440d-8dbd-5a71f6164cf2)

Company: https://www.keypedia.com/companies/seraplex-inc/bf5f27b4-6fb3-4639-925e-2f5a67c2c23a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d